news
Global PrEP access falls short of target for HIV prevention
Over 3.5 million people globally received PrEP in 2023 for HIV prevention, with 75% in Africa. This number is still far from the 2025 target of 10 million, despite modeling showing cost-effectiveness for easy access. The Lancet Global Health commentary calls for redesigning service delivery to scale up. It's a clear signal that current strategies aren't reaching enough people, leaving immune systems vulnerable to a preventable virus.
Over 3.5 million people globally received PrEP in 2023 for HIV prevention, with 75% in Africa. This number is still far from the 2025 target of 10 million, despite modeling showing cost-effectiveness for easy access. The Lancet Global Health commentary calls for redesigning service delivery to scale up. It's a clear signal that current strategies aren't reaching enough people, leaving immune systems vulnerable to a preventable virus.
The architecture take
I read this and instantly thought about the quiet hum of the nervous system when it's not under constant threat. Preventing HIV isn't just about a drug; it's about reducing the chronic stress load, the fear, the constant vigilance that comes with high-risk exposure. When PrEP works, it protects the immune system directly by blocking viral replication, but also indirectly by lowering that pervasive, background anxiety.
This isn't a niche concern. If 75% of PrEP users are in Africa, and even there they're missing targets, it means access to critical health interventions is still a postcode lottery. They're talking about redesigning service delivery, which is code for making it easier, more affordable, and less stigmatized to get a medication that fundamentally alters a person's biological future. Watch how health systems respond — this pushes for decentralized, community-level health, not just top-down directives.